1. Home
  2. RLYB vs LIDR Comparison

RLYB vs LIDR Comparison

Compare RLYB & LIDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • LIDR
  • Stock Information
  • Founded
  • RLYB 2018
  • LIDR 2013
  • Country
  • RLYB United States
  • LIDR United States
  • Employees
  • RLYB N/A
  • LIDR N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • LIDR Auto Parts:O.E.M.
  • Sector
  • RLYB Health Care
  • LIDR Consumer Discretionary
  • Exchange
  • RLYB Nasdaq
  • LIDR Nasdaq
  • Market Cap
  • RLYB 14.4M
  • LIDR 14.8M
  • IPO Year
  • RLYB 2021
  • LIDR N/A
  • Fundamental
  • Price
  • RLYB $0.35
  • LIDR $0.92
  • Analyst Decision
  • RLYB Hold
  • LIDR Hold
  • Analyst Count
  • RLYB 3
  • LIDR 1
  • Target Price
  • RLYB $15.00
  • LIDR N/A
  • AVG Volume (30 Days)
  • RLYB 329.4K
  • LIDR 576.8K
  • Earning Date
  • RLYB 08-07-2025
  • LIDR 08-04-2025
  • Dividend Yield
  • RLYB N/A
  • LIDR N/A
  • EPS Growth
  • RLYB N/A
  • LIDR N/A
  • EPS
  • RLYB N/A
  • LIDR N/A
  • Revenue
  • RLYB $848,000.00
  • LIDR $246,000.00
  • Revenue This Year
  • RLYB N/A
  • LIDR $2,677.23
  • Revenue Next Year
  • RLYB N/A
  • LIDR $409.09
  • P/E Ratio
  • RLYB N/A
  • LIDR N/A
  • Revenue Growth
  • RLYB N/A
  • LIDR N/A
  • 52 Week Low
  • RLYB $0.22
  • LIDR $0.49
  • 52 Week High
  • RLYB $1.54
  • LIDR $4.30
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 53.64
  • LIDR 65.47
  • Support Level
  • RLYB $0.30
  • LIDR $0.71
  • Resistance Level
  • RLYB $0.38
  • LIDR $0.88
  • Average True Range (ATR)
  • RLYB 0.04
  • LIDR 0.09
  • MACD
  • RLYB 0.00
  • LIDR 0.00
  • Stochastic Oscillator
  • RLYB 49.29
  • LIDR 89.21

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

Share on Social Networks: